DR. CALUM MACRAE, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

LifeMD, Inc.

Filing Date	Source Excerpt
2024-04-29	MacRae Director Agreement On April 26, 2024, the Company and Dr. MacRae entered into a director agreement, whereby, as compensation for his services as a member of the Board, Dr. MacRae will receive three grants, totaling 50,000 restricted shares of common stock, with a grant of 16,500 restricted shares on April 26, 2024 vesting on April 26, 2025, a grant of 16,500 restricted shares on April 26, 2025 vesting on April 26, 2026 and a grant of 17,000 restricted shares on April 26, 2026 vesting on April 26, 2027.

Filing Date

Source Excerpt

2024-04-29

MacRae Director Agreement On April 26, 2024, the Company and Dr. MacRae entered into a director agreement, whereby, as compensation for his services as a member of the Board, Dr. MacRae will receive three grants, totaling 50,000 restricted shares of common stock, with a grant of 16,500 restricted shares on April 26, 2024 vesting on April 26, 2025, a grant of 16,500 restricted shares on April 26, 2025 vesting on April 26, 2026 and a grant of 17,000 restricted shares on April 26, 2026 vesting on April 26, 2027.

Data sourced from SEC filings. Last updated: 2026-02-03